Causes of Death Among Patients Supported by Extracorporeal Membrane Oxygenation
<h3>Background</h3> Mortality for patients who are critically ill receiving extracorporeal membrane oxygenation (ECMO) support (venovenous or venoarterial) is high, but the proximal causes of death have not been characterized fully. <h3>Research Question</h3> We aimed to characterize the reasons for death in patients who underwent cannulation while receiving venoarterial or venovenous ECMO. <h3>Study Design and Methods</h3> This was a retrospective multicenter observational cohort study of adult patients who underwent cannulation for ECMO and who died while receiving ECMO at 6 medical centers in the United States. <h3>Results</h3> We categorized the causes of death for 751 patients who underwent cannulation for ECMO. We summarized and compared baseline patient characteristics among the 6 sites. Reasons for death were comorbid withdrawal of life-sustaining therapy (n = 248 [33%]), progressive hemodynamic shock (n = 200 [27%]), neurologic withdrawal of life-sustaining therapy (n = 135 [18%]), cardiogenic shock (n = 126 [17%]), respiratory failure (n = 31 [4.1%]), and equipment failure (n = 11 [1.5%]). Comorbid withdrawal of life-sustaining therapy was the most common cause of death in patients who underwent cannulation for both venoarterial (n = 141 [29%]) and venovenous (n = 107 [41%]) ECMO. The rate of palliative care consultation differed among sites. <h3>Interpretation</h3> This study showed that most deaths result from comorbid withdrawal of life-sustaining therapy and that death or withdrawal because of refractory respiratory failure and cardiogenic shock account for a lower proportion of deaths in patients receiving ECMO. Our efforts to reduce mortality in patients receiving ECMO should account for the proportion of deaths attributable to comorbid withdrawal of life-sustaining therapy.
Authors
- Shahzad Shaefi (ORCID: https://orcid.org/0000-0002-6832-3282)
- Raghu R. Seethala (ORCID: https://orcid.org/0000-0002-3501-7094)
- Brian O’Gara (ORCID: https://orcid.org/0000-0002-3868-7499)
- Jen‐Ting Chen (ORCID: https://orcid.org/0000-0002-8530-2520)
- Daniel Knox (ORCID: https://orcid.org/0000-0002-8991-1235)
- David M. Furfaro (ORCID: https://orcid.org/0000-0001-6514-699X)
- Jerome Crowley (ORCID: https://orcid.org/0000-0001-8833-8281)
- Ari Moskowitz (ORCID: https://orcid.org/0009-0003-5223-3121)
- Annette Ilg (ORCID: https://orcid.org/0000-0002-8153-077X)
- I. Aimlin
- Renata P. Lerner
- Nidhi Kavi
- Marjan Rahmanian (ORCID: https://orcid.org/0009-0006-3861-8131)
- Alison S. Witkin (ORCID: https://orcid.org/0000-0002-4650-2116)
- Michelle N. Gong (ORCID: https://orcid.org/0000-0001-7952-5384)
- Ryan Gardner (ORCID: https://orcid.org/0000-0002-0303-229X)
- Anthony Carlese (ORCID: https://orcid.org/0000-0003-4555-3939)
- Anthony Manasia
- Amira Mohamed (ORCID: https://orcid.org/0009-0002-8381-1265)
- Malorie Butera
- Daniel Gutteridge
- Christie Horner
Institutions
- Intermountain Healthcare (US)
- Brigham and Women's Hospital (US)
- Beth Israel Deaconess Medical Center (US)
- Montefiore Medical Center (US)
- Massachusetts General Hospital (US)
- Mount Sinai Medical Center (US)
- University of California San Francisco Medical Center (US)
- University of San Francisco (US)
Publication Details
- Journal
- CHEST Critical Care
- Published
- 2024-12-06
- DOI
- https://doi.org/10.1016/j.chstcc.2024.100114
- Citations
- 3
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.55
Funders
- LivaNova
- Fresenius Medical Care North America
- National Institutes of Health
- Centers for Disease Control and Prevention
- Agency for Healthcare Research and Quality